CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-24 | BARBIER REMI President and CEO | Option exercise · Stock Option (Right to Buy) | −14,285 | $16.87 | $241K | 0 |
| 2023-05-24 | BARBIER REMI President and CEO | Option exercise · Stock Option (Right to Buy) | −71,428 | $16.87 | $1.2M | 0 |
| 2023-05-10 | ROBERTSON SANFORD Director | Option exercise | +3,571 | $19.60 | $70K | 851,138 |
| 2023-05-10 | ROBERTSON SANFORD Director | Option exercise | +3,571 | $16.66 | $59K | 854,709 |
| 2023-05-10 | ROBERTSON SANFORD Director | Option exercise | +2,142 | $16.66 | $36K | 856,851 |
| 2023-05-10 | ROBERTSON SANFORD Director | Option exercise · Stock Option (Right to Buy) | −3,571 | $19.60 | $70K | 0 |
| 2023-05-10 | ROBERTSON SANFORD Director | Option exercise · Stock Opton (Right to Buy) | −3,571 | $16.66 | $59K | 0 |
| 2023-05-10 | ROBERTSON SANFORD Director | Option exercise · Stock Opton (Right to Buy) | −2,142 | $16.66 | $36K | 0 |
| 2023-05-04 | SCANNON PATRICK J MD PHD Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $22.34 | $447K | 20,000 |
| 2023-05-04 | ROBERTSON SANFORD Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $22.34 | $447K | 25,000 |
| 2023-05-04 | ROBERTSON SANFORD Director | Grant or award · Stock Option (Right to Buy) | +5,000 | $22.34 | $112K | 5,000 |
| 2023-05-04 | O DONNELL MICHAEL J Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $22.34 | $447K | 20,000 |
| 2023-05-04 | GUSSIN ROBERT Z Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $22.34 | $447K | 25,000 |
| 2023-05-04 | GUSSIN ROBERT Z Director | Grant or award · Stock Option (Right to Buy) | +5,000 | $22.34 | $112K | 5,000 |
| 2023-05-04 | Barry Richard Director | Grant or award · Stock Option (Right to Buy) | +20,000 | $22.34 | $447K | 25,000 |
| 2023-05-04 | Barry Richard Director | Grant or award · Stock Option (Right to Buy) | +5,000 | $22.34 | $112K | 5,000 |
| 2023-05-01 | GUSSIN ROBERT Z Director | Option exercise | +2,142 | $16.66 | $36K | 10,552 |
| 2023-05-01 | GUSSIN ROBERT Z Director | Option exercise | +3,571 | $16.66 | $59K | 14,123 |
| 2023-05-01 | GUSSIN ROBERT Z Director | Option exercise | +3,571 | $19.60 | $70K | 17,694 |
| 2023-05-01 | GUSSIN ROBERT Z Director | Shares withheld for taxes | +7,077 | $23.34 | $165K | 10,617 |
Page 5 of 17 · 324 trades